Table 3.
Data set | Subjects | Cases/Controls | OR (95% CI)* | P-value |
---|---|---|---|---|
eMERGE | All AF cases | 1,547 / 3,128 | 0.89 (0.83–0.95) | 0.0006 |
All AF cases, GRS adjusted† | 1,547 / 3,128 | 0.90 (0.83–0.98) | 0.02 | |
All AF cases, SNP adjusted‡ | 1,547 / 3,128 | 0.90 (0.81–1.01) | 0.06 | |
BioVU EHR set | All AF | 1,206 / 2,405 | 0.90 (0.85–0.98) | 0.01 |
BioVU AF registry | All AF | 1,022 / 668 | 0.90 (0.81–0.99) | 0.03 |
Lone AF | 220 / 668 | 0.87 (0.74–1.03) | 0.1 | |
Paroxysmal | 444 / 668 | 0.90 (0.80–1.02) | 0.09 | |
Persistent | 259 / 668 | 0.93 (0.80–1.08) | 0.34 |
The odds-ratio is per standard deviation increase in the genetically predicted PR interval. All association models are adjusted for age, gender and 3 PCs.
Adjusted for genetic risk scores for atrial fibrillation and the PR interval.
Adjusted for SNPs (n=17) previously associated with AF or the PR interval by GWAS.